Novai (private company)
See something wrong or missing? Let us know
Offices:London
Business model:B2B
Novai is a biotechnology startup, commercialising DARC technology, an exploratory retinal biomarker for use in Age-related macular degeneration & glaucoma clinical studies.
DARC Technology combines an innovative patented biologic with a state-of-the-art AI algorithm. For the first time in humans, using standard imaging equipment, DARC is able to identify cellular level disease activity.
A biomarker is a measurable indicator of the presence & severity of disease.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Novai
| Name | Criteria | |
|---|---|---|
 |
Sano Genetics
77%
|
|
|
Clustermarket
77%
|
|
 |
Atai Life Sciences
72%
|
|
|
Causaly
72%
|
|
|
Overwatch Research
72%
|
|
|
bit.bio
72%
|
|
 |
Monocl
68%
|
|
 |
DeepLife
68%
|
|
 |
Sarcura
67%
|
|
 |
Scailyte
67%
|
|
Belgium
Netherlands
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain